HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David L Morris Selected Research

Expectorants (Mucolytics)

1/2022A novel method for potentiation of chemotherapy in soft tissue sarcomas with BromAc.
1/2022Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19.
10/2021Role of human nucleoside transporters in pancreatic cancer and chemoresistance.
6/2017Assessment of a novel mucolytic solution for dissolving mucus in pseudomyxoma peritonei: an ex vivo and in vitro study.
10/2012Potential mucolytic agents for mucinous ascites from pseudomyxoma peritonei.
5/2012Mucolysis by ascorbic acid and hydrogen peroxide on compact mucin secreted in pseudomyxoma peritonei.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David L Morris Research Topics

Disease

112Neoplasms (Cancer)
05/2022 - 03/2002
82Neoplasm Metastasis (Metastasis)
06/2022 - 03/2002
53Peritoneal Neoplasms
06/2022 - 05/2005
40Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 03/2002
26Pseudomyxoma Peritonei
05/2022 - 04/2009
24Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2008
15Mesothelioma
06/2022 - 02/2009
11Ascites
01/2019 - 02/2010
10Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019 - 07/2010
9Carcinoma (Carcinomatosis)
05/2022 - 07/2009
8Appendiceal Neoplasms (Appendix Cancer)
05/2022 - 02/2010
8Hepatocellular Carcinoma (Hepatoma)
09/2017 - 04/2004
8Liver Neoplasms (Liver Cancer)
01/2014 - 03/2005
7Ovarian Epithelial Carcinoma
01/2021 - 05/2012
7Inflammation (Inflammations)
07/2015 - 05/2011
6Adenocarcinoma
01/2019 - 08/2009
6Autoimmune Diseases (Autoimmune Disease)
01/2019 - 05/2011
6Hemorrhage
01/2019 - 12/2003
6Breast Neoplasms (Breast Cancer)
03/2016 - 09/2010
5Disease Progression
01/2021 - 03/2012
5Insulin Resistance
01/2017 - 04/2007
4Lymphatic Metastasis
05/2018 - 07/2009
4Obesity
12/2014 - 12/2009
4Hyperglycemia
05/2014 - 10/2013
3Sarcoma (Soft Tissue Sarcoma)
01/2022 - 12/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 11/2010
3Wounds and Injuries (Trauma)
05/2020 - 04/2005
3Neoplasms, Cystic, Mucinous, and Serous
12/2017 - 01/2017
3Cholangiocarcinoma
09/2017 - 02/2010
3Type 2 Diabetes Mellitus (MODY)
01/2017 - 05/2014
3Liver Diseases (Liver Disease)
10/2014 - 01/2006
3Melanoma (Melanoma, Malignant)
03/2014 - 05/2010
3Body Weight (Weight, Body)
10/2013 - 12/2009
3Margins of Excision
10/2011 - 06/2006
2COVID-19
01/2022 - 01/2021
2Pancreatic Fistula (Pancreatic Fistulas)
11/2021 - 05/2010
2Colonic Neoplasms (Colon Cancer)
01/2021 - 11/2017
2Neutropenia
05/2020 - 10/2007
2Thrombosis (Thrombus)
01/2019 - 03/2005
2Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2017 - 05/2010

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
04/2017 - 09/2009
13Pharmaceutical PreparationsIBA
01/2021 - 05/2005
13Yttrium-90IBA
03/2015 - 02/2010
11Albendazole (Albenza)FDA Link
03/2015 - 05/2005
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2015 - 10/2008
8MucinsIBA
05/2022 - 10/2009
8CytokinesIBA
01/2022 - 03/2011
8Carcinoembryonic AntigenIBA
01/2017 - 03/2002
6bromelain and acetylcysteine drug combinationIBA
01/2022 - 01/2021
6Expectorants (Mucolytics)IBA
01/2022 - 05/2012
5Indicators and Reagents (Reagents)IBA
01/2020 - 02/2009
5Biological ProductsIBA
03/2018 - 02/2012
5Biomarkers (Surrogate Marker)IBA
01/2017 - 08/2012
5Interleukin-6 (Interleukin 6)IBA
08/2015 - 11/2002
470-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2021 - 01/2014
4AntigensIBA
03/2016 - 07/2010
4Insulin (Novolin)FDA Link
01/2015 - 12/2013
4Minocycline (Cyclops)FDA LinkGeneric
01/2015 - 05/2012
4AnthelminticsIBA
01/2014 - 05/2005
4Urokinase Plasminogen Activator ReceptorsIBA
01/2013 - 11/2009
3Mitomycin (Mitomycin-C)FDA LinkGeneric
06/2022 - 08/2009
3GemcitabineFDA Link
10/2021 - 01/2021
3Cisplatin (Platino)FDA LinkGeneric
03/2021 - 10/2012
3Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 08/2009
3PlatinumIBA
01/2021 - 10/2012
3monepantelIBA
01/2021 - 01/2014
3Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 02/2012
3catch-relaxing peptide (Mytilus)IBA
01/2020 - 10/2018
3SolutionsIBA
06/2017 - 09/2008
3Bromelains (Bromelain)IBA
10/2015 - 01/2014
3EnzymesIBA
01/2015 - 10/2008
3LeptinIBA
05/2014 - 04/2007
3AsbestosIBA
02/2014 - 02/2009
3Paclitaxel (Taxol)FDA LinkGeneric
02/2013 - 08/2007
3Glucose (Dextrose)FDA LinkGeneric
08/2010 - 04/2007
2Irinotecan (Camptosar)FDA LinkGeneric
05/2020 - 02/2012
2InterferonsIBA
01/2019 - 03/2011
2Interferon Type IIBA
01/2019 - 06/2015
2Tumor Biomarkers (Tumor Markers)IBA
03/2018 - 08/2012

Therapy/Procedure

97Drug Therapy (Chemotherapy)
06/2022 - 03/2002
87Cytoreduction Surgical Procedures
06/2022 - 06/2007
50Hyperthermic Intraperitoneal Chemotherapy
06/2022 - 11/2008
29Therapeutics
05/2022 - 03/2005
23Radiofrequency Ablation
06/2015 - 11/2003
12Hepatectomy
01/2019 - 07/2007
8Microspheres (Microsphere)
10/2014 - 09/2008
8Cryotherapy (Therapy, Cold)
04/2012 - 11/2002
7Metastasectomy
06/2022 - 12/2009
6Aftercare (After-Treatment)
02/2014 - 12/2010
5Length of Stay
05/2020 - 01/2004
5Radiotherapy
09/2017 - 08/2006
4Blood Transfusion (Blood Transfusions)
08/2019 - 02/2011
4Cryosurgery
10/2012 - 11/2002
3Operative Time
05/2020 - 01/2017
3Liver Transplantation
10/2014 - 04/2012
3Salvage Therapy
02/2013 - 10/2010
3Electrodes (Electrode)
07/2005 - 10/2003
2Gastrectomy
10/2019 - 01/2016
2Transplantation
09/2017 - 08/2008
2Splenectomy
08/2017 - 04/2005